Does ERYTHROMYCIN Cause Mobility decreased? 96 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Mobility decreased have been filed in association with ERYTHROMYCIN (Erythromycin). This represents 1.3% of all adverse event reports for ERYTHROMYCIN.
96
Reports of Mobility decreased with ERYTHROMYCIN
1.3%
of all ERYTHROMYCIN reports
92
Deaths
93
Hospitalizations
How Dangerous Is Mobility decreased From ERYTHROMYCIN?
Of the 96 reports, 92 (95.8%) resulted in death, 93 (96.9%) required hospitalization, and 92 (95.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERYTHROMYCIN. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does ERYTHROMYCIN Cause?
Drug hypersensitivity (3,813)
Nausea (560)
Drug ineffective (502)
Vomiting (497)
Rash (471)
Hypersensitivity (401)
Diarrhoea (378)
Urticaria (361)
Dyspnoea (344)
Fatigue (344)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ERYTHROMYCIN Alternatives Have Lower Mobility decreased Risk?
ERYTHROMYCIN vs ERYTHROMYCIN ETHYLSUCCINATE
ERYTHROMYCIN vs ERYTHROMYCIN LACTOBIONATE
ERYTHROMYCIN vs ERYTHROPOIETIN
ERYTHROMYCIN vs ESCHERICHIA COLI
ERYTHROMYCIN vs ESCITALOPRAM